EMA Qualifies First AI Tool for Diagnosing Inflammatory Liver Disease
The EMA has qualified AIM-NASH, the first AI tool for diagnosing inflammatory liver disease (MASH) using biopsy samples. This innovation enhances clinical trial reliability by minimizing variability in assessing disease …
EMA Qualifies First AI Tool for Diagnosing Inflammatory Liver Disease Read More